Abiraterone Acetate Tablet, Film Coated
Product Images NDC 0378-6921

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Abiraterone Acetate (NDC 0378-6921). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Abiraterone Acetate Tablets, Usp 250 mg Bottle Label (Image 01)

Abiraterone Acetate Tablets, Usp 250 mg Bottle Label (Image 01)
This is a medication label for a tablet. It is advised to keep the container tightly closed and out of reach of children. The tablet must be swallowed whole, not chewed or rushed. The recommended storage temperature is between 20-25°C. The usual dosage depends on the prescription information provided along with the medication. The name of the manufacturing company is Mylan Pharmaceuticas located in Morgantown, USA.*
FDA Label Image

Abiraterone Acetate Structural Formula (Image 02)

FDA Label Image

Figure 1: Kaplan-meier Overall Survival Curves In Cou-aa-301 (intent-to-treat Analysis) (Image 03)

FDA Label Image

Figure 2: Kaplan Meier Overall Survival Curves In Cou-aa-302 (Image 04)

FDA Label Image

Figure 3: Kaplan Meier Curves Of Radiographic Progression-free Survival In Cou-aa-302 (intent-to-treat Analysis) (Image 05)

FDA Label Image

Image 06

FDA Label Image

Image 08

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.